- Home
- CNTX vs INVE Comparison
CNTX vs INVE Comparison
Compare CNTX & INVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- INVE
- Stock Information
- Founded
- CNTX 2015
- INVE 1990
- Country
- CNTX United States
- INVE United States
- Employees
- CNTX N/A
- INVE N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- INVE Computer peripheral equipment
- Sector
- CNTX Health Care
- INVE Technology
- Exchange
- CNTX Nasdaq
- INVE Nasdaq
- Market Cap
- CNTX 75.6M
- INVE 85.9M
- IPO Year
- CNTX 2021
- INVE 1997
- Fundamental
- Price
- CNTX $1.26
- INVE $3.92
- Analyst Decision
- CNTX Strong Buy
- INVE Strong Buy
- Analyst Count
- CNTX 7
- INVE 2
- Target Price
- CNTX $5.20
- INVE $5.50
- AVG Volume (30 Days)
- CNTX 500.2K
- INVE 34.7K
- Earning Date
- CNTX 11-10-2025
- INVE 11-06-2025
- Dividend Yield
- CNTX N/A
- INVE N/A
- EPS Growth
- CNTX N/A
- INVE N/A
- EPS
- CNTX N/A
- INVE 3.12
- Revenue
- CNTX N/A
- INVE $23,538,000.00
- Revenue This Year
- CNTX N/A
- INVE N/A
- Revenue Next Year
- CNTX N/A
- INVE $9.06
- P/E Ratio
- CNTX N/A
- INVE $1.27
- Revenue Growth
- CNTX N/A
- INVE N/A
- 52 Week Low
- CNTX $0.49
- INVE $2.86
- 52 Week High
- CNTX $2.46
- INVE $4.29
- Technical
- Relative Strength Index (RSI)
- CNTX 56.22
- INVE 57.32
- Support Level
- CNTX $1.19
- INVE $3.43
- Resistance Level
- CNTX $1.50
- INVE $4.05
- Average True Range (ATR)
- CNTX 0.15
- INVE 0.19
- MACD
- CNTX -0.02
- INVE 0.04
- Stochastic Oscillator
- CNTX 39.78
- INVE 76.28
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About INVE Identiv Inc.
Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has one reportable segment: the IoT Business segment. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific.